3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Head & Neck
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
43
Breast Neoplasms
31
Prostatic Neoplasms
27
Colorectal Neoplasms
26
Lung Neoplasms
17
Hematopoietic and Lymphatic System Neoplasm
12
Ovarian Neoplasms
11
Hematologic Neoplasms
11
Uterine Cervical Neoplasms
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Interventions
Iodine-131
14
trametinib
9
dabrafenib
9
Thyroidectomy
9
Surgical Procedures, Operative
9
lenvatinib
8
Thyroxine
8
Magnetic Resonance Spectroscopy
8
pembrolizumab
7
Paclitaxel
7
anlotinib
6
Thyrotropin Alfa
6
selpercatinib
5
Sorafenib
5
Saline Solution
5
Radiofrequency Ablation
5
Everolimus
5
pazopanib
4
Vemurafenib
4
Sunitinib
4
Radiotherapy
4
Nivolumab
4
Fluorodeoxyglucose F18
4
Dexmedetomidine
4
Cyclophosphamide
4
Biopsy, Fine-Needle
4
Biopsy
4
Bevacizumab
4
apatinib
3
Triiodothyronine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Neoplasms
×
Interviews as Topic
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled
NCT06322160
2024-09-19
HANSOM
Royal Marsden NHS Foundation Trust
Completed
19 enrolled